BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31298931)

  • 1. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
    Mani J; Neuschäfer J; Resch C; Rutz J; Maxeiner S; Roos F; Chun FK; Juengel E; Blaheta RA
    Nutr Cancer; 2020; 72(3):528-537. PubMed ID: 31298931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanism.
    Juengel E; Afschar M; Makarević J; Rutz J; Tsaur I; Mani J; Nelson K; Haferkamp A; Blaheta RA
    Int J Mol Med; 2016 Mar; 37(3):843-50. PubMed ID: 26781971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.
    Tsaur I; Makarević J; Juengel E; Gasser M; Waaga-Gasser AM; Kurosch M; Reiter M; Wedel S; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
    Br J Cancer; 2012 Aug; 107(5):847-55. PubMed ID: 22782340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
    Makarević J; Rutz J; Juengel E; Kaulfuss S; Tsaur I; Nelson K; Pfitzenmaier J; Haferkamp A; Blaheta RA
    PLoS One; 2014; 9(10):e110244. PubMed ID: 25333694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of integrin subunits in DU-145/AR prostate cancer cells.
    Nagakawa O; Akashi T; Hayakawa Y; Junicho A; Koizumi K; Fujiuchi Y; Furuya Y; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2004 Oct; 12(4):837-41. PubMed ID: 15375509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gleditsia sinensis Thorn Attenuates the Collagen-Based Migration of PC3 Prostate Cancer Cells through the Suppression of α2β1 Integrin Expression.
    Ryu S; Park KM; Lee SH
    Int J Mol Sci; 2016 Mar; 17(3):328. PubMed ID: 26950116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro.
    Makarević J; Tsaur I; Juengel E; Borgmann H; Nelson K; Thomas C; Bartsch G; Haferkamp A; Blaheta RA
    Life Sci; 2016 Feb; 147():137-42. PubMed ID: 26827990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro.
    Tsaur I; Rutz J; Makarević J; Juengel E; Gust KM; Borgmann H; Schilling D; Nelson K; Haferkamp A; Bartsch G; Blaheta RA
    World J Urol; 2015 Jul; 33(7):1051-6. PubMed ID: 25179012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific S-nitrosylation of integrin α6 increases the extent of prostate cancer cell migration by enhancing integrin β1 association and weakening adherence to laminin-1.
    Isaac J; Tarapore P; Zhang X; Lam YW; Ho SM
    Biochemistry; 2012 Dec; 51(48):9689-97. PubMed ID: 23106339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins.
    Klominek J; Sumitran Karuppan S; Hauzenberger D
    Int J Cancer; 1997 Sep; 72(6):1034-44. PubMed ID: 9378538
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kwon OY; Ryu S; Choi JK; Lee SH
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630092
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
    Ahmed N; Riley C; Rice G; Quinn M
    Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amygdalin Decreases Adhesion and Migration of MDA-MB-231 and MCF-7 Breast Cancer Cell Lines.
    Mosayyebi B; Mohammadi L; Kalantary-Charvadeh A; Rahmati M
    Curr Mol Pharmacol; 2021 Oct; 14(4):667-675. PubMed ID: 32778045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells.
    Tsaur I; Thomas A; Monecke M; Zugelder M; Rutz J; Grein T; Maxeiner S; Xie H; Chun FK; Rothweiler F; Cinatl J; Michaelis M; Haferkamp A; Blaheta RA
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.
    Lee YC; Jin JK; Cheng CJ; Huang CF; Song JH; Huang M; Brown WS; Zhang S; Yu-Lee LY; Yeh ET; McIntyre BW; Logothetis CJ; Gallick GE; Lin SH
    Mol Cancer Res; 2013 Apr; 11(4):405-17. PubMed ID: 23339185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.
    Lochter A; Navre M; Werb Z; Bissell MJ
    Mol Biol Cell; 1999 Feb; 10(2):271-82. PubMed ID: 9950676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo.
    Rabinovitz I; Nagle RB; Cress AE
    Clin Exp Metastasis; 1995 Nov; 13(6):481-91. PubMed ID: 7586806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins.
    Mueller FJ; Serobyan N; Schraufstatter IU; DiScipio R; Wakeman D; Loring JF; Snyder EY; Khaldoyanidi SK
    Stem Cells; 2006 Nov; 24(11):2367-72. PubMed ID: 17071855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.
    Festuccia C; Angelucci A; Gravina G; Eleuterio E; Vicentini C; Bologna M
    Exp Cell Res; 2002 Oct; 280(1):1-11. PubMed ID: 12372334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
    Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Waaga-Gasser A; Haferkamp A; Blaheta RA
    BMC Cancer; 2011 Aug; 11():375. PubMed ID: 21867506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.